EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Generic: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Zydus Pharmaceuticals USA Inc.Manufacturer
ORALRoute
EMTRICITABINEActive Substance
2020-02-28Original Approval

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is FDA application ANDA212689, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FOETAL EXPOSURE DURING PREGNANCY
47 reports
2
EXPOSURE DURING PREGNANCY
37 reports
3
MATERNAL EXPOSURE DURING PREGNANCY
22 reports
4
ABORTION SPONTANEOUS
21 reports
5
DRUG EXPOSURE DURING PREGNANCY
14 reports
6
ANAEMIA
13 reports
7
DRUG INTERACTION
13 reports
8
PYREXIA
12 reports
9
VOMITING
12 reports
10
DIARRHOEA
11 reports